Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osama Karim Abed

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|October 30, 2014
[Fatal acute pancreatitis caused by severe hypertriglyceridaemia]Osama Karim Abed, Mats Lindberg, Shadi Andos
Danish Medical Journal|June 21, 2014
Clinical information on admission is insufficient to determine the appropriate isolation regimen for acute gastroenteritisFlorence Skyum, Osama Karim Abed, Christian Backer Mogensen
Alimentary Pharmacology & Therapeutics|September 19, 2022
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitisEmilie Kristine Dahl, Osama Karim Abed, Jens Kjeldsen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2019
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel diseaseSteffen Bank, Mette Julsgaard, Osama Karim Abed, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|October 30, 2014
[Fatal acute pancreatitis caused by severe hypertriglyceridaemia]Osama Karim Abed, Mats Lindberg, Shadi Andos
Danish Medical Journal|June 21, 2014
Clinical information on admission is insufficient to determine the appropriate isolation regimen for acute gastroenteritisFlorence Skyum, Osama Karim Abed, Christian Backer Mogensen
Alimentary Pharmacology & Therapeutics|September 19, 2022
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitisEmilie Kristine Dahl, Osama Karim Abed, Jens Kjeldsen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2019
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel diseaseSteffen Bank, Mette Julsgaard, Osama Karim Abed, et al.
Pageof 1